Possible involvement of endocannabinoids in the increase of morphine consumption in maternally deprived rat

Neuropharmacology

Volumn 65, Issue , 2013, Pages 193-199

  Naudon, Laurent ^a,b,c   Piscitelli, Fabiana ^d   Giros, Bruno ^a,b,c,e   Di Marzo, Vincenzo ^d   Daugé, Valérie ^a,b,c  

^a INSERM   (France)

^b CNRS   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d CNR   (Italy)

^e MCGILL UNIVERSITY   (Canada)

Author keywords

Endocannabinoids; Maternal deprivation; Morphine consumption; Rat; Selective CB1 antagonist inverse agonist; SR141716A

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ANANDAMIDE; CANNABINOID; CANNABINOID 1 RECEPTOR; ENDOCANNABINOID; MORPHINE; OPIATE; RIMONABANT;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAUDATE NUCLEUS; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; CORPUS STRIATUM; DRUG BRAIN LEVEL; DRUG USE; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MATERNAL DEPRIVATION; MESENCEPHALON; NONHUMAN; NUCLEUS ACCUMBENS; PERINATAL PERIOD; PRIORITY JOURNAL; PUTAMEN; QUANTITATIVE ANALYSIS; RAT; REWARD;

AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; BRAIN; ENDOCANNABINOIDS; FEMALE; MALE; MATERNAL DEPRIVATION; MORPHINE; MORPHINE DEPENDENCE; PREGNANCY; RATS; RATS, LONG-EVANS;

EID: 84870883049     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2012.10.008     Document Type: Article

References (55)

1. R.C. Belue, A.C. Howlett, T.M. Westlake, and D.E. Hutchings The ontogeny of cannabinoid receptors in the brain of postnatal and aging rats Neurotoxicol. Teratol. 17 1995 25 30
2. F. Berrendero, N. Sepe, J.A. Ramos, V. Di Marzo, and J.J. Fernàndez-Ruiz Analysis of cannabinoid receptor binding and mRNA expression and endogenous cannabinoid contents in the developing rat brain during late gestation and early postnatal period Synapse 33 1999 181 191
3. M. Biscaia, B. Fernàndez, A. Higuera-Matas, M. Miguèns, M.P. Viveros, C. Garcìa-Lecumberri, and E. Ambrosio Sex-dependent effects of periadolescent exposure to the cannabinoid agonist CP-55,940 on morphine self-administration behaviour and the endogenous opioid system Neuropharmacology 54 2008 863 873
4. T. Bisogno, S. Maurelli, D. Melck, L. De Petrocellis, and V. Di Marzo Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes J. Biol. Chem. 272 1997 3315 3323
5. T. Bisogno, F. Berrendero, G. Ambrosino, M. Cebeira, J.A. Ramos, J.J. Fernandez-Ruiz, and V. Di Marzo Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function Biochem. Biophys. Res. Commun 256 1999 377 380
6. S. Caillé, and L.H. Parsons SR141716A reduces the reinforcing properties of heroin but not heroin-induced increases in nucleus accumbens dopamine in rats Eur. J. Neurosci. 18 2003 3145 3149
7. S. Caillé, L. Alvarez-Jaimes, D.G. Polis, and L.H. Parson Specific alterations of extracellular endocannabinoid levels in the nucleus accumbens by ethanol, heroin, and cocaine self-administration J. Neurosci. 27 2007 3695 3702
8. F. Chaperon, P. Soubrié, A.J. Puech, and M.H. Thiébot Involvement of central cannabinoid (CB1) receptors in the establishment of place conditioning in rats Psychopharmacology 135 1998 324 332
9. K.P. Chiang, A.L. Gerber, J.C. Sipe, and B.F. Cravatt Reduced cellular expression and activity of the P129T mutant of human fatty acid amide hydrolase: evidence for a link between defects in the endocannabinoid system and problem drug use Hum. Mol. Genet. 13 2004 2113 2119
10. D.L. Cichewicz, and S.P. Welch Modulation of oral morphine antinociceptive tolerance and naloxone-precipitated withdrawal signs by oral delta 9-tetrahydrocannabinol J. Pharmacol. Exp. Ther. 305 2003 812 817
11. G. Colombo, R. Agabio, G. Diaz, C. Lobina, R. Reall, and G.L. Gessa Appetitive suppression and weight loss after the cannabinoid antagonist SR141716 Life Sci. 63 1998 113 117
12. B.F. Cravatt, K. Demarest, M.P. Patricelli, M.H. Bracey, D.K. Giang, B.R. Martin, and A.H. Lichtman Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase Proc. Natl. Acad. Sci. U S A 98 2001 9371 9376
13. T.J. De Vries, J.R. Homberg, R. Binnekade, H. Raaso, and A.N. Schoffelmeer Cannabinoid modulation of the reinforcing and motivational properties of heroin-associated cues in rats Psychopharmacology 168 2003 164 169
14. W.A. Devane, L. Hanus, A. Bruer, R.G. Pertwee, L.A. Stevenson, G. Griffin, D. Gibson, A. Mandelbaum, A. Etinger, and R. Mechoulam Isolation and structure of a brain constituent that binds to the cannabinoid receptor Science 258 1992 1946 1949
15. V. Di Marzo, and L. Cristino Why endocannabinoids are not all alike Nat. Neurosci. 11 2008 124 126
16. V. Di Marzo, and I. Matias Endocannabinoid control of food intake and energy balance Nat. Neurosci. 8 2005 585 589
17. V. Di Marzo, S.K. Goparaju, L. Wang, J. Liu, S. Bàtkai, Z. Jàrai, F. Fezza, G.I. Miura, R.D. Palmiter, T. Sugiura, and G. Kunos Leptin-regulated endocannabinoids are involved in maintaining food intake Nature 410 2001 822 825
18. M. Ellgren, S.M. Spano, and Y.L. Hurd Adolescent cannabis exposure alters opiate intake and opioid limbic neuronal populations in adult rats Neuropsychopharmacology 32 2007 607 615
19. W. Gonsiorek, C. Lunn, X. Fan, S. Narula, D. Lundell, and R.W. Hipkin Endocannabinoid 2-arachidonoyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide Mol. Pharmacol. 57 2000 1045 1050
20. J. Haller, I. Barna, B. Barsvari, K. Gyimesi Pelczer, S. Yasar, L.V. Panlilio, and S. Goldberg Interactions between environmental aversiveness and the anxiolytic effects of enhanced cannabinoid signaling by FAAH inhibition in rats Psychopharmacology 204 2009 607 616
21. S. Higgs, C.M. Williams, and T.C. Kirkham Cannabinoid influences on palatability: microstructural analysis of sucrose drinking after delta(9)-tetrahydrocannabinol, anandamide, 2-arachidonoylglycerol and SR141716 Psychopharmacology 165 2003 370 377
22. B.G. Kelley, and S.A. Thayer Delta 9-tetrahydrocannabinol antagonizes endocannabinoid modulation of synaptic transmission between hippocampal neurons in culture Neuropharmacology 46 2004 709 715
23. T.C. Kirkham, C.M. Williams, F. Fezza, and V. Di Marzo Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol Br. J. Pharmacol. 136 2002 550 557
24. L. Lamota, F.J. Bermudez-Silva, E.M. Marco, R. Llorente, A. Gallego, F. Rodriguez de Fonseca, and M.P. Viveros Effects of adolescent nicotine and SR147778 (Surinabant) administration on food intake, somatic growth and metabolic parameters in rats Neuropharmacology 54 2008 194 205
25. C. Ledent, O. Valverde, G. Cossu, F. Petitet, J.F. Aubert, F. Beslot, G.A. Bohme, A. Imperato, T. Pedrazzini, B.P. Roques, G. Vassart, W. Fratta, and M. Parmentier Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice Science 228 1999 401 404
26. R. Llorente, A. Llorente-Berzal, S. Petrosino, E.M. Marco, C. Guaza, C. Prada, M. Lopez-Gallardo, and V. Di Marzo Gender dependent cellular and biochemical effects of maternal deprivation on the hippocampus of neonatal rats; a possible role for the endocannabinoid system Dev. Neurobiol. 68 2008 1334 1347
27. A. Llorente-Berzal, S. Fuentes, H. Gagliano, M. López-Gallardo, A. Armario, M.P. Viveros, and R. Nadal Sex-dependent effects of maternal deprivation and adolescent cannabinoid treatment on adult rat behaviour Addict. Biol. 16 2011 624 637
28. K. Mackie, W.A. Devane, and B. Hille Anandamide, an endogenous cannabinoid, inhibits calcium currents as an agonist in N18 neuroblastoma cells Mol. Pharmacol. 44 1993 498 503
29. G. Marsicano, C.T. Wotjak, S.C. Azad, T. Bisogno, G. Rammes, M.G. Cascio, H. Hermann, J. Tang, C. Hofmann, W. Zieglgansberger, V. Di Marco, and B. Lutz The endogenous cannabinoid system controls extinction of aversive memories Nature 418 2002 530 534
30. E. Martín-García, A. Burokas, M. Martín, F. Berrendero, B. Rubi, C. Kiesselbach, A. Heyne, J.D. Gispert, O. Millàn, and R. Maldonado Central and peripheral consequences of the chronic blockade of CB1 cannabinoid receptor with rimonabant or taranabant J. Neurochem. 112 2010 1338 1351
31. M. Mas-Nieto, B. Pommier, E.T. Tzavara, A. Caneparo, S. Da Nascimento, G. Le Fur, B.P. Roques, and F. Noble Reduction of opioid dependence by the CB(1) antagonist SR141716A in mice: evaluation of the interest in pharmacotherapy of opioid addiction Br. J. Pharmacol. 132 2001 1809 1816
32. R. Mechoulam, S. Ben-Shabat, L. Hanus, M. Ligumsky, N.E. Kaminski, A.R. Schatz, A. Gopher, S. Almog, B.R. Martin, and D.R. Compton Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors Biochem. Pharmacol. 50 1995 83 90
33. L. Morel, B. Giros, and V. Daugé Adolescent exposure to chronic delta-9-tetrahydrocannabinol blocks opiate dependence in maternally deprived rats Neuropsychopharmacology 34 2009 2469 2476
34. M. Navarro, M.R. Carrera, W. Fratta, O. Valverde, G. Cossu, L. Fattore, J.A. Chowen, R. Gòmez, I. del Arco, M.A. Villanùa, R. Maldonado, G.F. Koob, and F. Rodriguez de Fonseca Functional interaction between opioid and cannabinoid receptors in drug self-administration J. Neurosci. 21 2001 5344 5350
35. U. Pagotto, G. Marsicano, D. Cota, B. Lutz, and R. Pasquali The emerging role of the endocannabinoid system in endocrine regulation and energy balance Endocr. Rev. 27 2006 73 100
36. G. Paxinos, and C. Watson The Rat Brain in Stereotaxic Coordinates 1997 Academic New York
37. 9-tetrahydrocannabivarin Brit. J. Pharmacol. 153 2008 199 215
38. M. Pistis, S. Perra, G. Pillolla, M. Melis, A.L. Muntoni, and G.L. Gessa Adolescent exposure to cannabinoids induces long-lasting changes in the response to drugs of abuse of rat midbrain dopamine neurons Biol. Psychiatry 56 2004 86 94
39. D. Ramesh, G.Z. Ross, J.E. Schlosburg, R.A. Owens, R.A. Abdullah, S.G. Kinsey, J.Z. Long, D.K. Nomura, L.J. Sim-Selley, B.F. Cravatt, H.I. Akbarali, and A.H. Lichtman Blockade of endocannabinoid hydrolytic enzymes attenuates precipitated opioid withdrawal symptoms in mice J. Pharmacol. Exp. Ther. 339 2011 173 185
40. F. Rodriguez de Fonseca, J.A. Ramos, A. Bonnin, and J.J. Fernandez-Ruiz Presence of cannabinoid binding sites in the brain from early postnatal ages Neuroreport 4 1993 135 138
41. 9-tetrahydrocannabinol switches from agonist to antagonist depending on firing rate Mol. Pharmacol. 75 2009 892 900
42. J.E. Schlosburg, J.L. Blankman, J.Z. Long, D.K. Nomura, B. Pan, S.G. Kinsey, P.T. Nguyen, D. Ramesh, L. Booker, J.J. Burston, E.A. Selley, L.J. Sim-Selley, Q.S. Liu, A.H. Lichtman, and B.F. Cravatt Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system Nat. Neurosci. 13 2010 1113 1119
43. M.E. Singh, I.S. McGregor, and P.E. Mallet Perinatal exposure to delta-9 tetrahydrocannabinol alters heroin-induced place conditioning and Fos-immunoreactivity Neuropsychopharmacology 31 2006 58 69
44. J.C. Sipe, K. Chiang, A.L. Gerber, E. Beutler, and B.F. Cravatt A missense mutation in human fatty acid amide hydrolase associated with problem drug use Proc. Natl. Acad. Sci. U S A 99 2002 8394 8399
45. M. Solinas, L.V. Panlilio, K. Antoniou, L.A. Pappas, and S.R. Goldberg The cannabinoid CB1 antagonist N-piperidinyl-5-(4-chlorophenyl)-1-(2,4- dichlorophenyl)-4-methylpyrazole-3-carboxamide (SR-141716A) differentially alters the reinforcing effects of heroin under continuous reinforcement, fixed ratio, and progressive ratio schedules of drug self-administration in rats J. Pharmacol. Exp. Ther. 306 2003 93 102
46. M. Solinas, L.V. Panlilio, G. Tanda, A. Makriyannis, S.A. Matthews, and R. Goldberg Cannabinoid agonists but not inhibitors of endogenous cannabinoid transport or metabolism enhance the reinforcing efficacy of heroin in rats Neuropsychopharmacology 30 2005 2046 2057
47. M. Solinas, S.R. Goldberg, and D. Piomelli The endocannabinoid system in brain reward Br. J. Pharmacol. 154 2008 369 383
48. G. Tanda, and S.R. Goldberg Cannabinoids: reward, dependence, and underlying neurochemical mechanisms- a review of recent preclinical data Psychopharmacology 169 2003 115 134
49. O. Valverde, F. Noble, F. Beslot, V. Daugé, M.C. Fournié-Zaluski, and B.P. Roques Delta9-tetrahydrocannabinol releases and facilitates the effects of endogenous enkephalins: reduction in morphine withdrawal syndrome without change in rewarding effect Eur. J. Neurosci. 13 2001 1816 1824
50. V. Vazquez, J. Penit-Soria, C. Durand, M.J. Besson, B. Giros, and V. Daugé Maternal deprivation increases vulnerability to morphine dependence and disturbs the enkephalinergic system in adulthood J. Neurosci. 25 2005 4453 4462
51. V. Vazquez, S. Farley, B. Giros, and V. Daugé Maternal deprivation increases behavioural reactivity to stressful situations in adulthood: suppression by the CCK2 antagonist L365,260 Psychopharmacology 181 2005 706 713
52. V. Vazquez, B. Giros, and V. Daugé Maternal deprivation specifically enhances vulnerability for opiate dependence Behav. Pharmacol. 17 2006 715 724
53. S.P. Vickers, L.J. Webster, A. Wyatt, C.T. Dourish, and G.A. Kennett Preferential effects of the cannabinoid CB1 receptor antagonist, SR141716, on food intake and body weight gain of obese (fa/fa) compared to lean Zucker rats Psychopharmacology 167 2003 103 111
54. D. Viganò, M. Valenti, M.G. Cascio, V. Di Marzo, D. Parolaro, and T. Rubinom Changes in endocannabinoid levels in a rat model of behavioural sensitization to morphine Eur. J. Neurosci. 20 2004 1849 1857
55. D. Viganò, C. Guidali, S. Petrosino, N. Realini, T. Rubino, V. Di Marzo, and D. Parolaro Involvement of the endocannabinoid system in phencyclidine-induced cognitive deficits modelling schizophrenia Int. J. Neuropsychopharmacol. 12 2009 599 614